Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | L330A |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 L330A lies within the tetramerization domain of the Tp53 protein (PMID: 20978130). L330A results in a monomeric Tp53 protein and altered subcellular localization in cultured cells, and decreased MDM2-mediated mono- and polyubiquitination in an in vitro assay (PMID: 29549180). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon9 TP53 L330A TP53 mutant TP53 inact mut TP53 L330A |
Transcript | NM_000546.6 |
gDNA | chr17:g.7673539_7673540delCTinsGC |
cDNA | c.988_989delCTinsGC |
Protein | p.L330A |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126113.2 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001276761.1 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407265.1 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126118.1 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126118.2 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001276760.3 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407267.1 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001276761.3 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001276760.1 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7673539_7673540delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
NM_001407263.1 | chr17:g.7669685_7669686delCTinsGC | c.988_989delCTinsGC | p.L330A | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|